Nevirapine Resistance in Human Immunodeficiency Virus Type 1-Positive Infants Determined Using Dried Blood Spots Stored for Up to Six Years at Room Temperature
Year: 2009
Type: article
Study design: Observational Study
Abstract: Dried blood spots that had been stored ambiently for 3 to 6 years lost approximately 1 log(10) of human immunodeficiency virus type 1 (HIV-1) RNA, but the majority could still be genotyped for resistance. Nevirapine resistance was found in 7/16 (43.5%) HIV-1-positive HIVNET 024 infants at 4 to 6 weeks, but no resistance was found at other time points.
Source: Journal of Clinical Microbiology
DOI: 10.1128/jcm.00254-09
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Health and Human Services, Boehringer Ingelheim, Harvard University, Johns Hopkins University, University of Alabama at Birmingham, University of Alabama, International Maternal Pediatric Adolescent AIDS Clinical Trials Network, National Institutes of Health, Center for AIDS Research, University of Washington, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, Office of AIDS Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Center for AIDS Research, University of North Carolina at Chapel Hill
Awards: STATISTICAL &CLINICAL COORDINATING CENTER (SC), G1467100060, HIV PREVENTION TRIALS UNIT - MALAWI, G1929754733, G2230551448, G2358511323, HIV PREVENTION TRIALS UNIT, G338662604, G3765052321, G5798171895, INTNL.VACC.EFFICACY TRIALS MASTER CONTRACT (IMC), International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT, The University of North Carolina Center for AIDS Research, G982464176
OpenAlex ID: W2112690333